함께 비교하는 진짜 ADC · Antibody · CGT 데이터

CGTBiologicstaleShanghai Unicar-Therapy Bio-med…Phase 2

ssCART-19 (ssCART-19)

B Cell Lymphoma · B Cell Lymphoma

#BCellLymphoma#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleTakedaPhase 2

CD19-CAR-T2 Cells (CD19-CAR-T2 Cells)

B Cell Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

ADCBiologicstaleDualityBio Inc.Phase 3

DB-1303/BNT323 (DB-1303/BNT323)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

ADCBiologicstaleGlaxoSmithKlinePhase 2

GSK3174998 (GSK3174998)

Neoplasms · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 11.1%임상시험 5상태 RECRUITING

ADCBiologicstaleSanofiPhase 2

Pegenzileukin (Pegenzileukin)

Plasma Cell Myeloma Refractory · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 92.9%임상시험 5상태 RECRUITING

CGTBiologicstaleBristol-Myers SquibbPhase 1

NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL (NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL)

Unspecified Adult Solid Tumor, Protocol Specific · Unspecified Adult Solid Tumor, Protocol

#UnspecifiedAdultSolidTumorProtoc#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleCell Medica LtdPhase 2

WT1 TCR-transduced T cells (WT1 TCR-transduced T cells)

Acute Myeloid Leukaemia; Chronic Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase2#세포유전치료#CAR-T+3

AntibodystaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#항체#면역항체+4

임상시험 5상태 DISCONTINUED

ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4

ADCBiologicstaleRayzeBio, Inc.Phase 2

RYZ101 (RYZ101)

Metastatic Breast Cancer; HER2-negative Breast Cancer · HER2

CGTBiologicstaleEssen BiotechPhase 1

Mesothelin-directed CAR-T cells (Mesothelin-directed CAR-T cells)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleAstraZenecaPhase 1

AZD7789 (AZD7789)

Advanced or Metastatic NSCLC · Advanced or Metastatic NSCLC

#AdvancedorMetastaticNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

AntibodystaleMerck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+4

효능 ORR 7.1%임상시험 5상태 RECRUITING

ADCBiologicstaleSanofiPhase 2

SAR3419 (SAR3419)

Diffuse Large B-cell Lymphoma · Acute Lymphocytic Leukaemia

#AcuteLymphocyticLeukaemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleGuangdong Ruishun Biotech Co., …Phase 1

CD19-CAR-DNT cells (CD19-CAR-DNT cells)

B-cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Talazoparib plus Irinotecan (Talazoparib plus Irinotecan)

Breast Neoplasms; Breast Cancer · HER2

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

효능 ORR 0.0%임상시험 5상태 RECRUITING

SGN-LIV1A (SGN-LIV1A)

Breast Neoplasms; Breast Cancer · HER2

CGTBiologicstaleGenethonPhase 2

효능 ORR 34%임상시험 5상태 RECRUITING

Autologous CD34+ cells transduced with WASP lentiviral vector (Autologous CD34+ cells transduced with WASP lentiviral vector)

Wiskott-Aldrich Syndrome · CD3

#CD3#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 8%임상시험 5상태 RECRUITING

CGTBiologicstaleGuangdong Ruishun Biotech Co., …Phase 1

CD19-CAR-DNT cells (RJMty19, RJMty19 (CD19-CAR-DNT cells))

B-cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleGV20 TherapeuticsPhase 2

GV20-0251 (GV20-0251)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstalePfizerPhase 2

BrECADD (BrECADD)

Hodgkin Lymphoma (Category) · Hodgkin Lymphoma (Category)

#HodgkinLymphomaCategory#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6002 (SYS6002)

Advanced Urothelial Carcinoma · Advanced Urothelial Carcinoma

#AdvancedUrothelialCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1